Sclerotherapy market future trends influencing growth

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Sclerotherapy Market Grow Between 2026 And 2030?

The sclerotherapy market has experienced robust expansion over recent years. This market is projected to expand from $1.21 billion in 2025 to $1.29 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, factors contributing to this growth include restricted understanding of available treatments, the prevalence of traditional sclerosing agents, infrequent uptake of cosmetic procedures, existing regulatory constraints, and elevated treatment expenses.

The sclerotherapy market is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. The upward trend during this projected timeframe is driven by factors such as the creation of safer sclerosants, advancements in delivery techniques, the proliferation of aesthetic clinics, the broadening scope of medical tourism, and enhanced insurance coverage. Key trends foreseen for the forecast period encompass the increasing adoption of minimally invasive procedures, sophisticated foam sclerosants, integrated combination therapies, a rise in outpatient treatments, and an uptick in medical tourism.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24394&type=smp

What Leading Drivers Are Supporting The Sclerotherapy Market Expansion?

The increasing occurrence of varicose veins and spider veins is anticipated to boost the expansion of the sclerotherapy market in the future. Varicose veins and spider veins are characterized by enlarged, twisted, or damaged veins, often visible beneath the skin, resulting from inadequate blood flow, typically in the legs. The increase in their prevalence is attributed to individuals spending extended periods sitting or standing, a habit frequently associated with contemporary workstyles. Sclerotherapy addresses these conditions through the targeted injection of a solution that effectively seals off the affected veins, thereby enhancing blood circulation and appearance. For illustration, in January 2024, data from the National Center for Biotechnology Information, a US-Based health information organization, indicated that in Brazil, 47.6% of the population had varicose veins (VVs). This prevalence was higher among non-pregnant women at 50.9%, compared to 37.9% in men. Consequently, the rising prevalence of varicose veins and spider veins is set to drive the growth of the sclerotherapy market.

Sclerotherapy Market Driver: Increasing Healthcare Expenditure Driving Market Growth Through Enhanced Access To Advanced Treatments

The growth in healthcare expenditure is projected to propel the sclerotherapy market forward. Healthcare expenditure represents the total spending on medical services, treatments, and health-related resources within a specific country or system. The surge in healthcare spending primarily stems from the escalating costs of advanced medical technologies, which, despite improving diagnosis and treatment, necessitate substantial investment in their development, equipment, and specialized personnel. Healthcare expenditure supports sclerotherapy by enabling funding for access to specialized treatments, medical staff, and advanced equipment. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that the UK’s healthcare expenditure in 2024 reached approximately $421.32 billion (£317 billion), marking a 6.5% increase compared to 2023. Therefore, the increase in healthcare expenditure is poised to drive the growth of the sclerotherapy market.

How Is The Sclerotherapy Market Categorized Across Its Segment Groups?

The sclerotherapy market covered in this report is segmented –

1) By Type: Liquid Sclerotherapy, Foam Sclerotherapy, Ultrasound-Guided Sclerotherapy

2) By Agents: Detergents, Chemical Irritants, Osmotic Agents

3) By Application: Varicose Veins, Spider Veins, Hemorrhoids

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Liquid Sclerotherapy: Polidocanol-based, Sodium Tetradecyl Sulfate (STS)-based, Hypertonic Saline-based

2) By Foam Sclerotherapy: Polidocanol Foam, STS Foam, Air-based Foam

3) By Ultrasound-Guided Sclerotherapy: Foam-guided, Liquid-guided, Combination Therapies

What Emerging Trends Are Seen In The Sclerotherapy Market?

Leading companies active in the sclerotherapy market are prioritizing strategic alliances to bolster their research capabilities, broaden their product portfolios, and reinforce their market presence through shared expertise and extensive global distribution networks. Advanced minimally invasive treatments for varicose veins refer to contemporary procedures such as sclerotherapy, laser therapy, and radiofrequency ablation that are effective in closing or removing damaged veins with minimal discomfort, swift recovery, and a reduced risk of complications. For example, in February 2025, Aakash Healthcare, an India-Based specialty hospital, collaborated with Medtronic plc, a US-based healthcare company, to establish a specialized vein clinic. This clinic provides advanced, minimally invasive treatments for varicose veins and various other vein-related conditions, ensuring expedited recovery and lasting health benefits for patients. Moreover, it also furnishes improved personalized treatment plans and post-treatment care, thereby ensuring a comprehensive approach to vein health and overall well-being.

Which Firms Are Influencing Competition In The Sclerotherapy Market?

Major companies operating in the sclerotherapy market are Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Olympus Corporation, Smith And Nephew plc, Teleflex Incorporated, Cook Medical, Merz Pharma GmbH And Co KGaA, AngioDynamics Inc, Bioniche Pharma Group Ltd, Omega Pharmaceuticals Pvt Ltd, Endo Flex, Kreussler, Vascular Solutions Inc, BTG International Ltd, Boston Biomedical Inc, Cardinal Health Inc, Terumo Corporation, B Braun Melsungen AG, BD Bard, MedAlliance SA

Get The Full Sclerotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/sclerotherapy-global-market-report

Which Region Accounts For The Largest Portion Of The Sclerotherapy Market?

North America was the largest region in the sclerotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sclerotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sclerotherapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sclerotherapy-global-market-report

Browse Through More Reports Similar to the Global Sclerotherapy Market 2026, By The Business Research Company

Cryotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cryotherapy-global-market-report

Sphygmomanometer Market Report

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Pressotherapy Systems Market Report

https://www.thebusinessresearchcompany.com/report/pressotherapy-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795